Tonix Pharmaceuticals Holding Corp Stock Nasdaq
Equities
US8902602015
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- USD | - |
|
Jul. 09 | Tonix Pharmaceuticals Prices $4 Million Public Offering; Shares Plunge | MT |
Jul. 09 | Tonix Pharmaceuticals Holding Corp. announced that it expects to receive $30 million in funding | CI |
Financials (USD)
Sales 2024 * | 13.92M | Sales 2025 * | 17.78M | Capitalization | 10.5M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -91M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-0.02
x | P/E ratio 2025 * |
-0.03
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.31% |
1st Jan change | Capi. | |
---|---|---|
+7.64% | 101B | |
+8.29% | 42.63B | |
+85.55% | 29.77B | |
-11.82% | 16.14B | |
+1.39% | 14.31B | |
-12.13% | 11.55B | |
+176.65% | 10.53B | |
+3.97% | 9.2B | |
-55.52% | 8.98B |